首页 >
法规速递
-
Document: 2024-2026 Work Plan of the Good Clinical Practice Inspectors Working Group (GCP IWG)-2025/3/17
2025-03-18查看详情 > -
Page: Methylphenidate product-specific bioequivelance guidance-2025/3/17
2025-03-18查看详情 > -
Page: Assessment templates and guidance-2025/3/17
2025-03-18查看详情 > -
Document: List of signals discussed at PRAC since September 2012-2025/3/17
2025-03-18查看详情 > -
Document: PRAC recommendations on signals adopted at the 10-13 February 2025 meeting-2025/3/17
2025-03-18查看详情 > -
Page: Contacts at the European Medicines Agency-2025/3/14
2025-03-17查看详情 > -
Document: Template for late submission of ICSRs to EV-2025/3/14
2025-03-17查看详情 > -
Document: PhV non-compliance notification contact points at National Competent Authority (NCA) level-2025/3/14
2025-03-17查看详情 > -
Document: Agenda - Management Board meeting: 13 March 2025-2025/3/14
2025-03-17查看详情 > -
Document: Scientific advice under Article 115(5) of Regulation (EU) 2019/6 on veterinary medicinal products, regarding the list of substances essential for the treatment of equine species and for which the withdrawal period for equine species shall be six
2025-03-17查看详情 >
